|
Nov 30, 1999
China: The NELCIN B3 trial
Prasad Kopparapu
USA
Prasad Kopparapu
Speaker of: China: The NELCIN B3 trial
Prasad Kopparapu Bio: Dr. Prasad Kopparapu is a research fellow in Dr. Christine Lovly’s lab at vanderbilt university medical center, studying circulating tumor cells in small cell lung cancer patients. Dr. Kopparapu got his PhD in Toxicology from Oregon state university where he worked on small molecule functional converters of anti-apoptotic Bcl-2 protein. Before coming to USA for his graduate studies Dr. Kopparapu worked in India as a clinical programmer. Dr. Kopparapu did his bachelor’s in chemical engineering from Osmania university and a master’s in biotechnology from JNT University in his hometown Hyderabad in India. In his free time Dr. Kopparapu likes spending time in nature and is also a yoga practitioner.
The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ISLB. The mention of any product, service, organization, activity, or therapy should not be construed as an ISLB endorsement.
Recent Episodes
Nov 01, 2025
Nov 23, 2024
Nov 21, 2023
Nov 30, 1999
David MacPherson
Nov 30, 1999
Kate Sutherland
Nov 30, 1999
Portia Thomas
Nov 30, 1999
Simon Heeke
Nov 30, 1999
Bruno Paiva
Nov 30, 1999
Catherine Meador
Nov 30, 1999
Carmen Garrido
Nov 30, 1999
Heather Wakelee
